ALLMedicine™ Ascites Center
Research & Reviews 3,294 results
Mayo Clinic Proceedings; Robateau A, Akusoba C et. al.
Sep 18th, 2021 - 51-Year-Old Man With Ascites and Abdominal Pain.|2021|Robateau A,Akusoba C,Greenlund L,|
Immunity, Inflammation and Disease; Kumagai A, Nara T et. al.
Sep 18th, 2021 - The efficacy assessment of human anti-IgE monoclonal antibodies (mAbs) in animal models before clinical trials is hampered due to the lack of cross-reactivity of anti-IgE mAbs between species. We developed CRE-DR (an anti-dog IgE monoclonal antibo...
Cancer Biomarkers : Section A of Disease Markers; Záveský L, Jandáková E et. al.
Sep 14th, 2021 - Ovarian cancer comprises the most lethal gynecologic malignancy and is accompanied by the high potential for the incidence of metastasis, recurrence and chemotherapy resistance, often associated with a formation of ascitic fluid. The differentiall...
Journal of Pediatric Gastroenterology and Nutrition; Mas E, Borrelli O et. al.
Sep 12th, 2021 - Octreotide, a somatostatin analogue, has been used for more than 20 years in children with gastrointestinal bleeding, chylothorax or chylous ascites, intestinal lymphangiectasia, pancreatitis, intestinal dysmotility, and severe diarrhoea; however,...
International Journal of Clinical Practice; Fang Y, Zhu H et. al.
Sep 8th, 2021 - Early detection of renal damage in cirrhosis is critical to prevent hepatorenal syndrome (HRS). Although shear wave elastography (SWE) is useful for the assessment of kidney stiffness, no study has yet investigated the clinical feasibility of SWE ...
Guidelines 5 results
Gut Aithal GP, Palaniyappan N et. al.
Oct 18th, 2020 - The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document. The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and managemen...
Clinical and Molecular Hepatology;
Jul 12th, 2018 - KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.|2018| ,|therapeutic use,therapeutic use,diagnosis,etiology,metabolism,therapy,therapeutic use,complications,diagnosis,therapy,complications,diagnosis,analysis,
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Paquet C, Yudin MH et. al.
Jan 25th, 2013 - One of the major consequences of pregnant women becoming infected by Toxoplasma gondii is vertical transmission to the fetus. Although rare, congenital toxoplasmosis can cause severe neurological or ocular disease (leading to blindness), as well a...
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Shmorgun D, Claman P et. al.
Nov 16th, 2011 - To review the clinical aspects of ovarian hyperstimulation syndrome and provide recommendations on its diagnosis and clinical management. These guidelines will assist in the early recognition and management of ovarian hyperstimulation. Early recog...
Hepatology (Baltimore, Md.); Runyon BA,
May 29th, 2009 - Management of adult patients with ascites due to cirrhosis: an update.|2009|Runyon BA, ,|diagnosis,etiology,therapy,diagnosis,etiology,therapy,etiology,therapy,complications,diagnosis,etiology,microbiology,therapy,
Drugs 84 results see all →
News 228 results
[Posted 05/26/2021] AUDIENCE: Patient, Health Professional, Pharmacy ISSUE: The FDA is restricting the use of the liver disease medicine Ocaliva (obeticholic acid) in patients having primary biliary cholangitis (PBC) with advanced cirrhosis of...
Apr 2nd, 2021 - Bradley J. Monk, MD: Katie Moore, I saved bevacizumab for you because you did a lot of these PARP inhibitor studies. Is there still a role for bevacizumab in recurrent ovarian cancer? And if so, tell us about that opportunity. Kathleen N. Moore...
Apr 2nd, 2021 - Bradley Monk, MD, FACOG, FACS: Matt and Shannon, I want to pivot here to the other most important abstract. I would say at ASCO [the American Society for Clinical Oncology annual meeting], the No. 1 and No. 2, I’m not sure one is better than the o...
Apr 2nd, 2021 - Bradley Monk, MD, FACOG, FACS: To finish up on PAOLA-1 as well, there are multiple things that we can do to help patients do better. We talked about treatment. The other thing that we can do to help patients do better is the quality of the surgery...
Apr 2nd, 2021 - Transcript: Richard S. Finn, MD: Unresectable liver cancer is a pretty diverse group of patients, right? For patients in the community, I always stress that they should get at least an opinion from a tertiary center, and certainly 1 that has a...